For infants six weeks of age and older, the FDA has approved the 20-valent pneumococcal conjugate vaccine.

Published Date: 04 May 2023

According to Pfizer, the FDA has given the pneumococcal conjugate vaccine Prevnar 20 permission to be used in infants and young children between the ages of 6 weeks and 17 years in order to prevent invasive pneumococcal disease (IPD).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot